Articles Tagged With:
-
FDA Actions
In this section: The agency tackles loperamide abuse, approves new breast cancer treatment, updates guidance on opioid cough and cold medications, promotes new opportunities to battle the opioid epidemic, and issues new indication for an irritable bowel drug.
-
Oral Medications for Toenail Fungus
Researchers compared terbinafine to placebo and other oral antifungals, including the azole antifungals (ketoconazole, itraconazole, and fluconazole) and Griseofulvin.
-
Fish Oil for Heart Patients?
The authors of a recent meta-analysis concluded that omega-3 fatty acids produced no effects on fatal or nonfatal coronary heart disease, nor on any major vascular events.
-
Alzheimer’s Drug Proven Ineffective
A once-promising drug produces disappointing results in a recent trial, to the dismay of researchers, patients, and families still searching for a cure.
-
Hemorrhage Control: Advances in Trauma Care
Massive hemorrhage is a devastating scenario. Early identification is essential to allow for prompt, potentially lifesaving interventions with the goal of rapid control of exsanguination.
-
Four Thrombocytopenic Emergencies
Thrombocytopenia is encountered commonly in the emergency department. In most instances, the emergency physician will not be able to determine the definitive diagnosis, but it is important that the initial evaluation be started in a timely manner and that appropriate specialists be consulted from the emergency department.
-
HIPAA Restricts Some Photography, but Not All
Photography in healthcare settings is difficult to control but could lead to HIPAA violations if not monitored. How much one should try to control people taking pictures and video can be difficult to determine.
-
HIPAA Allows Choice in Password Security, But Use Caution
Password security for electronic protected health information is a fundamental part of any HIPAA compliance program, but there is no one right way. HIPAA allows a great deal of choice in how to secure data with passwords, but one must choose carefully to ensure the information is protected from both casual snooping and sophisticated hacking.
-
Patient Access Now Dealing With Vendors Instead of Payers
Some payers are now outsourcing the authorization process to third-party vendors for high-tech radiology, infusion, or radiation oncology, which further complicates an already-difficult task for patient access.
-
Payers Want Evidence That Patient Already Tried First-line Therapy
Increasingly, payers require patients to try and fail “first-line” treatments before payers approve more costly treatments. Include supporting articles from the literature supporting off-label use, and ask physicians to supply statements on why the first-line therapy is not appropriate.